Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Chloroxine→

Chloroxine Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
773-76-2
Molecular formula
C9H5Cl2NO
Molecular weight
214.05 g/mol
Drug class
Halogenated hydroxyquinoline derivativetopical antifungal and antiseborrhoeic agent
Mechanism of action
Exerts local antimicrobial activity through metal chelation and interference with microbial enzyme systems; the precise clinical mechanism in scalp dermatoses is not fully established.
Indications / reported uses
  • Topical treatment of dandruff and seborrhoeic dermatitis of the scalp in countries where chloroxine shampoos or preparations remain authorised; product-specific use and availability vary

Sources: NLM MeSH — Chloroxine · PubMed — Chloroxine topical antifungal · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Chloroxine Environmental Risk Assessment (ERA) (the Chloroxine ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.